Carregant...
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Tuberculosis (TB) remains a threat to public health and is the leading cause of death globally. Isoniazid (INH) is an important first-line agent for the treatment of TB considering its early bactericidal activity. Resistance to INH is now the most common type of resistance. Resistance to INH reduces...
Guardat en:
| Publicat a: | Tuberc Respir Dis (Seoul) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953491/ https://ncbi.nlm.nih.gov/pubmed/31905429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2019.0065 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|